A Phase I Trial to Evaluate the Safety and Immunogenicity of a ChAdOx1 85A Vaccination with and without MVA85A Boost in Healthy BCG Vaccinated Adults

Trial Profile

A Phase I Trial to Evaluate the Safety and Immunogenicity of a ChAdOx1 85A Vaccination with and without MVA85A Boost in Healthy BCG Vaccinated Adults

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs ChAdOx1 85A (Primary) ; MVA 85A (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions
  • Most Recent Events

    • 10 May 2016 Status changed from active, no longer recruiting to completed.
    • 18 Aug 2015 Accrual to date is 100% according to United Kingdom Clinical Research Network record.
    • 18 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top